CANDEL THERAPEUTICS INC. - COMMON STOCK
6.6500
04-October-24 15:59:57
15 minutes delayed
Stocks
-0.0600
-0.89%
Today's range
6.4600 - 6.8800
ISIN
N/A
Source
NASDAQ
-
04 Oct 2024 09:00:45 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
03 Sep 2024 08:00:00 By Nasdaq GlobeNewswire
-
Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
13 Aug 2024 08:00:01 By Nasdaq GlobeNewswire
-
18 Jun 2024 08:00:00 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Join Russell 3000® Index
11 Jun 2024 08:00:00 By Nasdaq GlobeNewswire
-
FDA Grants Orphan Drug Designation for CAN-3110 for the Treatment of Recurrent High-Grade Glioma
30 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Present at the Jefferies Global Healthcare Conference
22 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
20 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
14 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
25 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
11 Apr 2024 09:00:00 By Nasdaq GlobeNewswire
-
09 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
04 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
28 Mar 2024 08:05:47 By Nasdaq GlobeNewswire
-
05 Mar 2024 16:30:00 By Nasdaq GlobeNewswire
-
CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma
13 Feb 2024 07:30:00 By Nasdaq GlobeNewswire
-
05 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Pancreatic Cancer
12 Dec 2023 08:00:01 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >